1. Kivipelto M, Mangialasche F, Ngandu T (2018) Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nat Rev Neurol 14 (11):653-666. doi:10.1038/s41582-018-0070-3
2. Solomon A, Mangialasche F, Richard E, Andrieu S, Bennett DA, Breteler M, Fratiglioni L, Hooshmand B, Khachaturian AS, Schneider LS, Skoog I, Kivipelto M (2014) Advances in the prevention of Alzheimer's disease and dementia. J Intern Med 275 (3):229-250. doi:10.1111/joim.12178
3. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C (2014) Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol 13 (8):788-794. doi:10.1016/S1474-4422(14)70136-X
4. Deckers K, van Boxtel MPJ, Schiepers OJG, de Vugt M, Muñoz Sánchez JL, Anstey KJ, Brayne C, Dartigues J-F, Engedal K, Kivipelto M, Ritchie K, Starr JM, Yaffe K, Irving K, Verhey FRJ, Köhler S (2015) Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry 30 (3):234-246. doi:10.1002/gps.4245
5. Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, Li Y, Li Y, Zhu M, Jiao H, Song Y, Shi Y, Zhang H, Gong M, Wei C, Tang Y, Fang B, Guo D, Wang F, Zhou A, Chu C, Zuo X, Yu Y, Yuan Q, Wang W, Li F, Shi S, Yang H, Zhou C, Liao Z, Lv Y, Li Y, Kan M, Zhao H, Wang S, Yang S, Li H, Liu Z, Wang Q, Qin W, Jia J, Group C (2020) Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health 5 (12):e661-e671. doi:10.1016/S2468-2667(20)30185-7
6. Hao L, Xing Y, Li X, Mu B, Zhao W, Wang G, Wang T, Jia J, Han Y (2019) Risk Factors and Neuropsychological Assessments of Subjective Cognitive Decline (plus) in Chinese Memory Clinic. Front Neurosci 13:846. doi:10.3389/fnins.2019.00846
7. Fratiglioni L, Paillard-Borg S, Winblad B (2004) An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol 3 (6):343-353
8. Marioni RE, Proust-Lima C, Amieva H, Brayne C, Matthews FE, Dartigues J-F, Jacqmin-Gadda H (2015) Social activity, cognitive decline and dementia risk: a 20-year prospective cohort study. BMC Public Health 15:1089. doi:10.1186/s12889-015-2426-6
9. Wang Z, Marseglia A, Shang Y, Dintica C, Patrone C, Xu W (2020) Leisure activity and social integration mitigate the risk of dementia related to cardiometabolic diseases: A population-based longitudinal study. Alzheimers Dement 16 (2):316-325. doi:10.1016/j.jalz.2019.09.003
10. Ma YH, Wang YY, Tan L, Xu W, Shen XN, Wang HF, Hou XH, Cao XP, Bi YL, Dong Q, Yang JL, Yu JT (2021) Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study. J Alzheimers Dis 81 (1):263-272. doi:10.3233/jad-201426
11. Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367 (6478). doi:10.1126/science.aau6977
12. D'Anca M, Fenoglio C, Serpente M, Arosio B, Cesari M, Scarpini EA, Galimberti D (2019) Exosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases. Frontiers in aging neuroscience 11:232. doi:10.3389/fnagi.2019.00232
13. Otero-Ortega L, Laso-García F, Gómez-de Frutos M, Fuentes B, Diekhorst L, Díez-Tejedor E, Gutiérrez-Fernández M (2019) Role of Exosomes as a Treatment and Potential Biomarker for Stroke. Transl Stroke Res 10 (3):241-249. doi:10.1007/s12975-018-0654-7
14. Nowak JS, Michlewski G (2013) miRNAs in development and pathogenesis of the nervous system. Biochem Soc Trans 41 (4):815-820. doi:10.1042/BST20130044
15. Kosik KS (2006) The neuronal microRNA system. Nat Rev Neurosci 7 (12):911-920
16. Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR (2015) Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers. PLoS ONE 10 (10):e0139233. doi:10.1371/journal.pone.0139233
17. Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A, Martins RN, Rowe CC, Macaulay SL, Masters CL, Hill AF (2015) Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry 20 (10):1188-1196. doi:10.1038/mp.2014.127
18. Gui Y, Liu H, Zhang L, Lv W, Hu X (2015) Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget 6 (35):37043-37053. doi:10.18632/oncotarget.6158
19. Sun Y, Zhen H, Wang L, Li B, Song Z, Deng Y, Liu Z, Ding J, Li T, Zhang W, Nie C, Rong S (2021) Plasma exosomal miRNA analysis of Alzheimer’s disease reveals the dysfunction of a neural network. bioRxiv. doi:https://doi.org/10.1101/2021.04.12.439575
20. Milagro FI, Miranda J, Portillo MP, Fernandez-Quintela A, Campión J, Martínez JA (2013) High-throughput sequencing of microRNAs in peripheral blood mononuclear cells: identification of potential weight loss biomarkers. PLoS ONE 8 (1):e54319. doi:10.1371/journal.pone.0054319
21. Davis CD, Ross SA (2008) Evidence for dietary regulation of microRNA expression in cancer cells. Nutr Rev 66 (8):477-482. doi:10.1111/j.1753-4887.2008.00080.x
22. Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, Jacob ST, Ghoshal K (2006) Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. Journal of cellular biochemistry 99 (3):671-678. doi:10.1002/jcb.20982
23. Stánitz É, Juhász K, Gombos K, Gőcze K, Tóth C, Kiss I (2015) Alteration of miRNA expression correlates with lifestyle, social and environmental determinants in esophageal carcinoma. Anticancer Res 35 (2):1091-1097
24. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Jr., Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7 (3):263-269. doi:10.1016/j.jalz.2011.03.005
25. Lu J, Li D, Li F, Zhou A, Wang F, Zuo X, Jia XF, Song H, Jia J (2011) Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals: a population-based study. J Geriatr Psychiatry Neurol 24 (4):184-190. doi:10.1177/0891988711422528
26. Huang YY, Qian SX, Guan QB, Chen KL, Zhao QH, Lu JH, Guo QH (2021) Comparative study of two Chinese versions of Montreal Cognitive Assessment for Screening of Mild Cognitive Impairment. Appl Neuropsychol Adult 28 (1):88-93. doi:10.1080/23279095.2019.1602530
27. Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, Cooper C, Fox N, Gitlin LN, Howard R, Kales HC, Larson EB, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbaek G, Teri L, Mukadam N (2017) Dementia prevention, intervention, and care. Lancet 390 (10113):2673-2734. doi:10.1016/S0140-6736(17)31363-6
28. Schwarzinger M, Pollock BG, Hasan OSM, Dufouil C, Rehm J, QalyDays Study G (2018) Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study. Lancet Public Health 3 (3):e124-e132. doi:10.1016/S2468-2667(18)30022-7
29. Kakutani S, Watanabe H, Murayama N (2019) Green Tea Intake and Risks for Dementia, Alzheimer's Disease, Mild Cognitive Impairment, and Cognitive Impairment: A Systematic Review. Nutrients 11 (5). doi:10.3390/nu11051165
30. Yu JT, Xu W, Tan CC, Andrieu S, Suckling J, Evangelou E, Pan A, Zhang C, Jia J, Feng L, Kua EH, Wang YJ, Wang HF, Tan MS, Li JQ, Hou XH, Wan Y, Tan L, Mok V, Tan L, Dong Q, Touchon J, Gauthier S, Aisen PS, Vellas B (2020) Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J Neurol Neurosurg Psychiatry 91 (11):1201-1209. doi:10.1136/jnnp-2019-321913
31. Cruice M, Worrall L, Hickson L (2011) Reporting on psychological well-being of older adults with chronic aphasia in the context of unaffected peers. Disability and rehabilitation 33 (3):219-228. doi:10.3109/09638288.2010.503835
32. Wang Z, Marseglia A, Shang Y, Dintica C, Patrone C, Xu W (2020) Leisure activity and social integration mitigate the risk of dementia related to cardiometabolic diseases: A population-based longitudinal study. Alzheimers Dement 16 (2):316-325. doi:10.1016/j.jalz.2019.09.003
33. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4 (1):44-57. doi:10.1038/nprot.2008.211
34. Huang da W, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37 (1):1-13. doi:10.1093/nar/gkn923
35. Camkurt MA, Acar Ş, Coşkun S, Güneş M, Güneş S, Yılmaz MF, Görür A, Tamer L (2015) Comparison of plasma MicroRNA levels in drug naive, first episode depressed patients and healthy controls. Journal of psychiatric research 69:67-71. doi:10.1016/j.jpsychires.2015.07.023
36. Wan Y, Liu Y, Wang X, Wu J, Liu K, Zhou J, Liu L, Zhang C (2015) Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder. PLoS ONE 10 (3):e0121975. doi:10.1371/journal.pone.0121975
37. De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV (2012) Alzheimer's disease. Sub-cellular biochemistry 65:329-352. doi:10.1007/978-94-007-5416-4_14
38. Peron R, Vatanabe IP, Manzine PR, Camins A, Cominetti MR (2018) Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer's Disease Treatment. Pharmaceuticals (Basel, Switzerland) 11 (1). doi:10.3390/ph11010012
39. Hébert SS, Horré K, Nicolaï L, Bergmans B, Papadopoulou AS, Delacourte A, De Strooper B (2009) MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis 33 (3):422-428. doi:10.1016/j.nbd.2008.11.009
40. O'Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer's disease. Annual review of neuroscience 34:185-204. doi:10.1146/annurev-neuro-061010-113613
41. Zoltowska KM, Berezovska O (2018) Dynamic Nature of presenilin1/γ-Secretase: Implication for Alzheimer's Disease Pathogenesis. Molecular neurobiology 55 (3):2275-2284. doi:10.1007/s12035-017-0487-5
42. Lauretti E, Dincer O, Praticò D (2020) Glycogen synthase kinase-3 signaling in Alzheimer's disease. Biochimica et biophysica acta Molecular cell research 1867 (5):118664. doi:10.1016/j.bbamcr.2020.118664
43. Wezyk M, Zekanowski C (2018) Role of BRCA1 in Neuronal Death in Alzheimer's Disease. ACS chemical neuroscience 9 (5):870-872. doi:10.1021/acschemneuro.8b00149
44. Kim B, Choi Y, Kim HS, Im HI (2019) Methyl-CpG Binding Protein 2 in Alzheimer Dementia. International neurourology journal 23 (Suppl 2):S72-81. doi:10.5213/inj.1938196.098
45. Thathiah A, Horré K, Snellinx A, Vandewyer E, Huang Y, Ciesielska M, De Kloe G, Munck S, De Strooper B (2013) β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease. Nature medicine 19 (1):43-49. doi:10.1038/nm.3023
46. Mrak RE, Griffin WS (2001) Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiology of aging 22 (6):903-908. doi:10.1016/s0197-4580(01)00287-1
47. Wang ZH, Xiang J, Liu X, Yu SP, Manfredsson FP, Sandoval IM, Wu S, Wang JZ, Ye K (2019) Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer's Disease. Cell reports 28 (3):655-669.e655. doi:10.1016/j.celrep.2019.06.054
48. Amidfar M, de Oliveira J, Kucharska E, Budni J, Kim YK (2020) The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease. Life sciences 257:118020. doi:10.1016/j.lfs.2020.118020
49. Acquaah-Mensah GK, Agu N, Khan T, Gardner A (2015) A regulatory role for the insulin- and BDNF-linked RORA in the hippocampus: implications for Alzheimer's disease. J Alzheimers Dis 44 (3):827-838. doi:10.3233/jad-141731
50. Kiyota T, Ingraham KL, Jacobsen MT, Xiong H, Ikezu T (2011) FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders. Proc Natl Acad Sci U S A 108 (49):E1339-1348. doi:10.1073/pnas.1102349108
51. Zhang W, Bai S, Yang J, Zhang Y, Liu Y, Nie J, Meng D, Shi R, Yao Z, Wang M, Wang H, Li C (2020) FoxO1 overexpression reduces Aβ production and tau phosphorylation in vitro. Neuroscience letters 738:135322. doi:10.1016/j.neulet.2020.135322
52. Shibuya Y, Chang CC, Huang LH, Bryleva EY, Chang TY (2014) Inhibiting ACAT1/SOAT1 in microglia stimulates autophagy-mediated lysosomal proteolysis and increases Aβ1-42 clearance. J Neurosci 34 (43):14484-14501. doi:10.1523/jneurosci.2567-14.2014
53. Helwak A, Kudla G, Dudnakova T, Tollervey D (2013) Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153 (3):654-665. doi:10.1016/j.cell.2013.03.043
54. Mader S, Brimberg L (2019) Aquaporin-4 Water Channel in the Brain and Its Implication for Health and Disease. Cells 8 (2). doi:10.3390/cells8020090
55. Terni B, Ferrer I (2015) Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer's Disease-Related Pathology. J Alzheimers Dis 46 (2):461-469. doi:10.3233/jad-142460
56. Nan Y, Han L, Zhang A, Wang G, Jia Z, Yang Y, Yue X, Pu P, Zhong Y, Kang C (2010) MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain research 1359:14-21. doi:10.1016/j.brainres.2010.08.074
57. Zhou Y, Song WM, Andhey PS, Swain A, Levy T, Miller KR, Poliani PL, Cominelli M, Grover S, Gilfillan S, Cella M, Ulland TK, Zaitsev K, Miyashita A, Ikeuchi T, Sainouchi M, Kakita A, Bennett DA, Schneider JA, Nichols MR, Beausoleil SA, Ulrich JD, Holtzman DM, Artyomov MN, Colonna M (2020) Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. Nature medicine 26 (1):131-142. doi:10.1038/s41591-019-0695-9
58. Yanaizu M, Washizu C, Nukina N, Satoh JI, Kino Y (2020) CELF2 regulates the species-specific alternative splicing of TREM2. Scientific reports 10 (1):17995. doi:10.1038/s41598-020-75057-x
59. Fineberg SK, Kosik KS, Davidson BL (2009) MicroRNAs potentiate neural development. Neuron 64 (3):303-309. doi:10.1016/j.neuron.2009.10.020
60. Gangaraju VK, Lin H (2009) MicroRNAs: key regulators of stem cells. Nature reviews Molecular cell biology 10 (2):116-125. doi:10.1038/nrm2621
61. Latronico MV, Condorelli G (2009) MicroRNAs and cardiac pathology. Nature reviews Cardiology 6 (6):419-429. doi:10.1038/nrcardio.2009.56
62. Negrini M, Nicoloso MS, Calin GA (2009) MicroRNAs and cancer--new paradigms in molecular oncology. Current opinion in cell biology 21 (3):470-479. doi:10.1016/j.ceb.2009.03.002
63. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D (2010) Physiological and pathological roles for microRNAs in the immune system. Nature reviews Immunology 10 (2):111-122. doi:10.1038/nri2708
64. Subramanian S, Steer CJ (2010) MicroRNAs as gatekeepers of apoptosis. J Cell Physiol 223 (2):289-298. doi:10.1002/jcp.22066
65. Lee YS, Dutta A (2009) MicroRNAs in cancer. Annual review of pathology 4:199-227. doi:10.1146/annurev.pathol.4.110807.092222
66. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nature reviews Cancer 6 (11):857-866. doi:10.1038/nrc1997
67. Wang M, Qin L, Tang B (2019) MicroRNAs in Alzheimer's Disease. Frontiers in genetics 10:153. doi:10.3389/fgene.2019.00153
68. Henzinger H, Barth DA, Klec C, Pichler M (2020) Non-Coding RNAs and SARS-Related Coronaviruses. Viruses 12 (12). doi:10.3390/v12121374
69. Penghui Yang YZ, Jie Li, Chuanyu Liu, Linnan Zhu, Jie Zhang, Yeya Yu, Wen-Jing Wang, Guanglin Lei, Jin Yan, Fang Sun, Chengrong Bian, Fanping Meng, Zhe Xu, Changqing Bai, Beiwei Ye, Yuanyuan Guo, Liumei Shu, Xiaoju Yuan, Ning Zhang, Yuhai Bi, Yi Shi, Guizhen Wu, Shaogeng Zhang, George F. Gao, Longqi Liu, William J. Liu, Hai-Xi Sun (2021) Down-regulated miR-451a as a feature in plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storm in COVID-19 patients. Cellular & Molecular Immunology. doi:https://doi.org/10.1038/s41423-021-00652-5
70. Driver JA, Beiser A, Au R, Kreger BE, Splansky GL, Kurth T, Kiel DP, Lu KP, Seshadri S, Wolf PA (2012) Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study. BMJ 344:e1442. doi:10.1136/bmj.e1442
71. He Y, Lin J, Kong D, Huang M, Xu C, Kim TK, Etheridge A, Luo Y, Ding Y, Wang K (2015) Current State of Circulating MicroRNAs as Cancer Biomarkers. Clin Chem 61 (9):1138-1155. doi:10.1373/clinchem.2015.241190
72. Musicco M, Adorni F, Di Santo S, Prinelli F, Pettenati C, Caltagirone C, Palmer K, Russo A (2013) Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study. Neurology 81 (4):322-328. doi:10.1212/WNL.0b013e31829c5ec1
73. Ou SM, Lee YJ, Hu YW, Liu CJ, Chen TJ, Fuh JL, Wang SJ (2013) Does Alzheimer's disease protect against cancers? A nationwide population-based study. Neuroepidemiology 40 (1):42-49. doi:10.1159/000341411
74. Kinnunen PJ (2010) Cancer linked to Alzheimer disease but not vascular dementia. Neurology 75 (13):1215; author reply 1216. doi:10.1212/WNL.0b013e3181f001fb
75. Stánitz É, Juhász K, Gombos K, Gőcze K, Tóth C, Kiss I (2015) Alteration of miRNA expression correlates with lifestyle, social and environmental determinants in esophageal carcinoma. Anticancer Res 35 (2):1091-1097
76. Stánitz E, Juhász K, Tóth C, Gombos K, Natali PG, Ember I (2013) Evaluation of MicroRNA expression pattern of gastric adenocarcinoma associated with socioeconomic, environmental and lifestyle factors in northwestern Hungary. Anticancer Res 33 (8):3195-3200